key: cord-1001237-w0mt034a authors: Yee, Jane; Unger, Lucy; Zadravecz, Frank; Cariello, Paloma; Seibert, Allan; Johnson, Michael Austin; Fuller, Matthew Joseph title: Novel coronavirus 2019 (COVID‐19): Emergence and implications for emergency care date: 2020-02-22 journal: J Am Coll Emerg Physicians Open DOI: 10.1002/emp2.12034 sha: 050bd7086c9fe8bd99dc67169a4db9241af4e0ec doc_id: 1001237 cord_uid: w0mt034a A novel coronavirus (COVID‐19) causing acute illness with severe symptoms has been isolated in Wuhan, Hubei Province, China. Since its emergence, cases have been found worldwide, reminiscent of severe acute respiratory syndrome and Middle East respiratory syndrome outbreaks over the past 2 decades. Current understanding of this epidemic remains limited due to its rapid development and available data. While occurrence outside mainland China remains low, the likelihood of increasing cases globally continues to rise. Given this potential, it is imperative that emergency clinicians understand the preliminary data behind the dynamics of this disease, recognize possible presentations of patients, and understand proposed treatment modalities. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. c ○ 2020 The Authors. JACEP Open published by Wiley Periodicals, Inc. on behalf of the American College of Emergency Physicians. WHAT IS A CORONAVIRUS? Based on genome sequencing, all known human coronaviruses have emerged from animal reservoirs. 1 Comparisons of the current COVID-19 outbreak are being made to 2 recently emerged coronaviruses from zoonotic spillover events; SARS- On Multiple reports have confirmed human-to-human transmission of the COVID-19. 8 When person-to-person spread has occurred with MERS-CoV and SARS-CoV, it is thought to have happened mainly via respiratory droplets produced when an infected person coughs or sneezes, similar to how Influenza and other respiratory pathogens spread. Inoculation via "fomite-to-face" contact is also likely a significant contributor to the spread of the virus. [8] [9] [10] Recently, the first case of asymptomatic transmission was reported, though the theory remains unproven. 11 This development raises concerns that the COVID-19 may be similar to other viruses such as chickenpox and measles in that transmission may be possible during the incubation period or by patients with mild disease. As of February 9, 2020, the mortality and morbidity rates of COVID-19 remain in flux. Currently, a case fatality rate (CFR) of slightly >3% has been reported, with some reports as high as 5%. 9,10 For comparison, MERS and SARS exhibited CFRs of 35% and 15%, respectively. 9 Mortality among COVID-19 victims seems highest for the elderly and those with multiple comorbidities. Knowledge of the COVID-19 presentation is limited by case reports of those presenting to the hospital and the unknown number of asymptomatic patients. To date, the average incubation period is estimated to be a median of 5 days with a range between 2 and 14 days. 8, 15 Based on an early descriptive study of patients admitted to a Wuhan regional referral hospital with confirmed COVID-19 pneumonia, the majority had fever (83%-98%) or cough (76%-82%) and roughly onethird had shortness of breath. Less common symptoms included myalgias (11%), rhinorrhea (10%), headache (8%), chest pain (2%), and gastrointestinal symptoms (3%). 2 Because Diagnosis of COVID-19 is performed via molecular assays of respiratory specimens at WHO-designated regional referral laboratories. 18 On February 7, the CDC began the distribution of test kits for regional Currently, the transmission dynamics of COVID-19 are poorly understood. Infection prevention guidance or COVID-19 is based upon guidance previously developed for MERS and SARS as well as interim guidelines provided by the WHO and CDC. 21, 22 In health care settings, triage and out-of-hospital protocols should identify a PUI before or upon ED arrival to minimize exposure to other patients and providers. Measures should include screening questions (including travel history) and respiratory and hand hygiene. If a patient needs to be hospitalized and an airborne infection isolation room is not available, the patient should be transferred to a facility with appropriate capabilities. Isolation rooms and care processes should be configured to minimize the number of health care personnel exposed to the patient as well as the duration of contact. It is paramount that all health care professionals use standard, contact, droplet, and airborne precautions in addition to an eye shield. PPE is especially important during aerosol-generating procedures (eg, intubation) when transmission is likely increased. 22, 29 After a patient vacates the room, it is unknown how long COVID-19 says airborne. Entrance to the vacated room requires respiratory protection for a period that is specific to the ventilation and clearance rates for the room. Not all COVID-19 exposed or afflicted patients will need hospital admission. However, the decision to discharge a PUI for home isolation should be made in consultation with the local public health authorities. 30 Patients should be directed to use appropriate hand hygiene, wear a simple facemask when around others, and remain isolated to a single room in the house whenever possible. 30 The WHO has declared COVID-19 a Public Health Emergency of International Concern. Currently, other seasonal infections cause more global disease than COVID-19. However, there are concerning elements to this emerging infectious agent, including a greater R 0 , initial greater estimated mortality, and no inherent immunity in global populations. Though data remains limited, it is imperative that emergency clinicians understand the dynamics of this emerging epidemic at both the individual-and population-based levels, learn how to recognize those patients at risk or suffering from COVID-19, and prepare to treat these patients in their clinical practice. Matthew Joseph Fuller MD https://orcid.org/0000-0002-2880-5463 Origin and evolution of pathogenic coronaviruses A novel coronavirus from patients with pneumonia in China Wuhan Municipal Health Committee Novel Coronavirus (2019-nCoV) Situation Summary | CDC Why snakes probably aren't spreading the new China virus ?_returnURL=https%3A%2F%2Flinkin ghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842×16000718%3Fs howall%3Dtrue. Accessed February 9 A novel coronavirus outbreak of global health concern. The Lancet Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Another decade, another coronavirus Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Pattern of early human-to-human transmission of Wuhan Report 2: estimating the potential total number of novel coronavirus cases in Wuhan City Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions Coronavirus 2019-nCoV Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet Coronavirus Has Now Spread To All Regions Of Mainland China [Internet]. NPR.org Statement on the meeting of the International Health Regulations 2005 Emergency Committee regarding the outbreak of novel coronavirus 2019 Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection Laboratory guidance OSHA Fact Sheet: Respiratory Infection Control: Respirators Versus Surgical Masks | Occupational Safety and Health Administration Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review Precautions | Basics | Infection Control | CDC Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial Facemasks and hand hygiene to prevent influenza transmission in households Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto Facemasks for the prevention of infection in healthcare and community settings Interim Guidance: Home Care for 2019-nCoV | CDC clinical-management-of-severe-acute-respiratory-infection-wh en-novel-coronavirus-(ncov)-infection-is-suspected Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: no, steroids are not a key component of the treatment regimen for SARS Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies Pattern of early human-to-human transmission of Wuhan 2019-nCoV Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients WHO | Middle East respiratory syndrome coronavirus (MERS-CoV) High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic Seasonal influenza in the United States, France, and Australia: transmission and prospects for control Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project